Influenza vaccination rates
Conditions
Interventions
Group 1: Analysis of influenza vaccination rates at general practitioners' offices (internal medicine, general medicine) before and after the implementation of the ImpfDocNE vaccination software and t
Sponsors
inav - privates Institut für angewandte Versorgungsforschung GmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The physician belongs to the specialty of general medicine or internal medicine.
Exclusion criteria
Exclusion criteria: - Individuals who work exclusively in private practice. - Individuals who do not offer primary care. - Individuals whose practices are currently participating in intervention studies to increase vaccination rates. - Individuals whose practices have participated in a measure to increase vaccination rates within the last 12 months prior to recruitment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is the rate of increase in the influenza vaccination rate among people over 60 years of age in Germany. The primary endpoint will be measured using a pre-post comparison of influenza vaccination rates before (time point t0) and after the implementation of the ImpfDocNE software (time points t3 = end of influenza season I (March 2027) and t4 = end of influenza season II (March 2028)). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are acceptance, success factors, hurdles, and obstacles to the measures to be implemented. These will be collected at two points in time (t1 = 3 months after implementation of the measures (December 2026), t2 = 6 months after implementation of the measures (March 2027)) as part of a process evaluation using qualitative interviews. | — |
Countries
Germany
Contacts
Public ContactFranziska Püschner
inav – privates Institut für angewandte Versorgungsforschung GmbH
Outcome results
None listed